A1AG1: (2R)-2-[(5R,6S,8R,9aS)-8-amino-1-oxo-5-(2-phenylethyl)hexahydro-1H-pyrrolo[1,2-a][1,4]diazepin-2(3H)-yl]-N-[(3,4-dichlorophenyl)methyl]-4-methylpentanamide
A1AG1 is a Ligand Of Interest in 9AVA designated by the Author
| Best-fitted instance in this entry | |
| Other instances in this entry |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 9AVA_A1AG1_B_302 | 71% | 74% | 0.079 | 0.947 | 0.38 | 0.52 | - | 1 | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_F_302 | 71% | 83% | 0.077 | 0.943 | 0.4 | 0.34 | 1 | - | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_H_302 | 70% | 77% | 0.081 | 0.947 | 0.37 | 0.47 | - | 1 | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_A_302 | 69% | 80% | 0.084 | 0.947 | 0.3 | 0.48 | - | - | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_K_302 | 68% | 78% | 0.081 | 0.941 | 0.3 | 0.51 | - | 1 | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_C_302 | 63% | 83% | 0.089 | 0.929 | 0.34 | 0.39 | - | - | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_I_302 | 62% | 74% | 0.09 | 0.928 | 0.34 | 0.55 | - | 1 | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_D_302 | 61% | 72% | 0.087 | 0.918 | 0.33 | 0.61 | - | 1 | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_G_302 | 61% | 72% | 0.094 | 0.927 | 0.32 | 0.61 | - | 2 | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_L_302 | 59% | 70% | 0.101 | 0.932 | 0.26 | 0.72 | - | 2 | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_J_302 | 46% | 72% | 0.121 | 0.9 | 0.3 | 0.64 | - | 2 | 0 | 0 | 100% | 1 |
| 9AVA_A1AG1_E_301 | 33% | 76% | 0.148 | 0.88 | 0.3 | 0.55 | - | 1 | 0 | 0 | 100% | 1 |














